REQUEST A DEMO
Total
USD $0.00
Search more companies

Imunomedica, A.S. (Czech Republic)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Imunomedica, A.S. Profile Updated: April 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Imunomedica, A.S. is an enterprise in Czech Republic, with the main office in Usti nad Labem. It operates in the Pharmaceutical Preparation Manufacturing industry. Imunomedica, A.S. was incorporated on October 01, 1996. Imunomedica, A.S. currently employs 25 - 49 (2023) people. In 2021, the company reported a net sales revenue drop of 18.29%. Its’ total assets recorded a growth of 0.24%. The net profit margin of Imunomedica, A.S. decreased by 0.5% in 2021.

Headquarters
Veslarska 118
Usti nad Labem; Ustecky; Postal Code: 40331

Contact Details: Purchase the Imunomedica, A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Imunomedica, A.S. report to view the information.
Outstanding Shares:
Purchase the Imunomedica, A.S. report to view the information.
Registered Capital:
Purchase the Imunomedica, A.S. report to view the information.
Incorporation Date:
October 01, 1996
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Imunomedica, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-18.29%
Total operating revenue
-18.27%
Operating profit (EBIT)
-18.05%
EBITDA
-15.84%
Net Profit (Loss) for the Period
-19.5%
Total assets
0.24%
Total equity
1.35%
Operating Profit Margin (ROS)
0.12%
Net Profit Margin
-0.5%
Return on Equity (ROE)
-3.87%
Quick Ratio
6.19%
Cash Ratio
5.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?